Delisting riskPopularity #4,891
Dermata Therapeutics (DRMA)
Developing Bioneedle-based skincare for consumer and professional channels.
$1.10
After hours−0.02 (−1.78%)
At close$1.12(−2.61%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.05% | 122.5K shares | |
|---|---|---|---|
| 13 holders · as of Jun 30, 2026 | |||
| Insiders | 34.31% | 1.38M shares | |
| 5 holders · as of Aug 18, 2026 | |||
| Other | 62.64% | 2.52M shares | |
| remainder | |||
4.02M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (4.02M in the company's Sep 23, 2026 report, 681.6K elsewhere); stakes use the report.
13F, as of Jun 30, 2026
13 holders · 122.5K shares · 7 new positions · 8 increased · 2 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 20.2K | 0.50% | −28.1K | Aug 12, 2026 |
| Welch & Forbes LLC | 20.0K | 0.50% | 0 | Jul 30, 2026 |
| State Street Corp | 18.7K | 0.47% | +18.7Knew | Aug 7, 2026 |
| UBS Group AG | 16.8K | 0.42% | −18.8K | Aug 13, 2026 |
| Susquehanna International Group, LLP | 16.0K | 0.40% | +16.0Knew | Aug 14, 2026 |
| XTX Topco Ltd | 14.8K | 0.37% | +14.8Knew | Aug 14, 2026 |
| Advisory Alpha, LLC | 10.0K | 0.25% | +10.0Knew | Aug 11, 2026 |
| Tower Research Capital LLC (TRC) | 3.9K | 0.10% | +3.1K | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Proehl Gerald T | 17.30% | 694.7K | 13D | Feb 23, 2026 |
| Armistice Capital, LLC | 9.99% | 672.1K | 13G | Aug 14, 2025 |
| Kyri K. Van Hoose | 9.00% | 384.4K | 13D | Jun 1, 2026 |
| Mitchell P. Kopin | 5.50% | 147.1K | 13G | Jan 2, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 16, 2026 | Kathleen D. Scottdirector | Sale | 11 | $1.19 | 0 |
| Feb 17, 2026 | Munera Maria E. Bedoya-Toroofficer: SVP, Regulatory Affairs | Purchase | 1,000 | $1.27 | 1,012 |
House and Senate disclosures
Not reported.
